Welcome to episode 148 of the AI in Action podcast, the show where we break down the hype and explore the impact that Data Science, Machine Learning and Artificial Intelligence are making on our everyday lives.
Powered by Alldus International, our goal is to share with you the insights of technologists and data science enthusiasts to showcase the excellent work that is being done within AI in the United States and Europe.
Today's guest is Luca Naef, Head of Analytics at VantAI in New York. Founded in 2019, VantAI pairs bleeding-edge machine learning techniques with deep systems biology expertise to build computational models that uncover hidden relationships between molecules, targets and diseases.
These models power a best-in-class solution that identifies and generates new molecular entities for targets of interest, repurposes existing molecules at any stage of development, uncovers accurate ADME and toxicological insights, and predicts adverse events likely to influence trial success from deep analysis of systems-based pharmacogenomics.
VantAI's in silico platform specializes in modelling complex protein-protein interactions, powering the discovery of biologics and protein degraders in addition to small-molecule drugs. It has helped leading biopharma partners to launch new development programs--or revitalize old ones--at a fraction of the time and cost of traditional methods.
In the episode, Luca will tell you about:
His journey to joining VantAI
VantAI’s mission within drug discovery
How Artificial Intelligence enhances drug discovery
Common challenges they need to overcome in HealthTech
What attracted him to join VantAI
What he looks for in the hiring process
What did you think of Luca's podcast? Where do you see the future of AI in the Healthcare industry heading in the next few years? We would love to hear your thoughts on this episode, so please leave a comment below.
If you would like to hear more from AI in Action then please subscribe and don’t forget to like and share with your friends on social media.